Judith Clements PhD

Judith Clements leads the Kallikrein Protease and Tumour Microenvironment Group Queensland University of Technology (QUT) where the focus of her research is the role of the prostate-specific antigen (PSA) (the current test for prostate cancer)-related peptidases and their utility as biomarkers or therapeutic targets for prostate and ovarian cancer. In recognition of her contribution to the kallikrein field internationally, she was awarded the prestigious EK Frey Werle Silver & Gold Medals, in 2000 & 2007, respectively. She was also recently elected as a member of the International Proteolysis Society Council for 2014-2017 and to the Australian Academy of Health and Medical Sciences in 2017. She has over 240 publications in scientific journals and collaborates widely with colleagues in the US, Canada, the UK and Europe. She initiated and led the Cancer Program at QUT from 1997-2014. She co-founded, and was Scientific Director (2009-2017), of the Australian Prostate Cancer Research Centre-Queensland, at QUT in Brisbane, Australia. She co-founded and directed until 2017 the national prostate cancer tissue bank – the Australian Prostate Cancer BioResource - which is a key resource (>6500 men recruited to date) that underpins prostate cancer research nationally and is co-leader of the Queensland node of the international genome wide association study consortium for prostate cancer, PRACTICAL, that has discovered >140 new genetic regions that are associated with prostate cancer risk.